1.
Malnique F, Queiroz GD, da Silva DGR, de Castro JĂșnior CR, Ceni VV, Mascari AC, et al. COMBINATION THERAPY WITH ROSUVASTATIN AND EZETIMIBE (TREZETE) IN VERY HIGH CARDIOVASCULAR RISK DYSLIPIDEMIA: EVIDENCE OF EFFICACY AND CLINICAL IMPACT. Editora [Internet]. 2025 Nov. 10 [cited 2025 Nov. 22];:316-30. Available from: https://sevenpubl.com.br/editora/article/view/8436